[go: up one dir, main page]

WO2006046114A3 - Osmotic dosage forms providing ascending drug release, and processes for their preparation - Google Patents

Osmotic dosage forms providing ascending drug release, and processes for their preparation Download PDF

Info

Publication number
WO2006046114A3
WO2006046114A3 PCT/IB2005/003183 IB2005003183W WO2006046114A3 WO 2006046114 A3 WO2006046114 A3 WO 2006046114A3 IB 2005003183 W IB2005003183 W IB 2005003183W WO 2006046114 A3 WO2006046114 A3 WO 2006046114A3
Authority
WO
WIPO (PCT)
Prior art keywords
dosage forms
processes
preparation
osmotic dosage
drug release
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/IB2005/003183
Other languages
French (fr)
Other versions
WO2006046114A2 (en
Inventor
Rajan Kumar Verma
Narayanan Badri Viswanathan
Rajeev Singh Raghuvanshi
Ashok Rampal
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ranbaxy Laboratories Ltd
Original Assignee
Ranbaxy Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Laboratories Ltd filed Critical Ranbaxy Laboratories Ltd
Publication of WO2006046114A2 publication Critical patent/WO2006046114A2/en
Publication of WO2006046114A3 publication Critical patent/WO2006046114A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)

Abstract

The present invention discloses osmotic dosage forms that provide drug release at an ascending release rate. Further, processes for the preparation of the osmotic dosage forms are also disclosed.
PCT/IB2005/003183 2004-10-25 2005-10-25 Osmotic dosage forms providing ascending drug release, and processes for their preparation Ceased WO2006046114A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN2081/DEL/2004 2004-10-25
IN2081DE2004 2004-10-25

Publications (2)

Publication Number Publication Date
WO2006046114A2 WO2006046114A2 (en) 2006-05-04
WO2006046114A3 true WO2006046114A3 (en) 2006-10-26

Family

ID=35871202

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2005/003183 Ceased WO2006046114A2 (en) 2004-10-25 2005-10-25 Osmotic dosage forms providing ascending drug release, and processes for their preparation

Country Status (1)

Country Link
WO (1) WO2006046114A2 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7419684B2 (en) 2006-12-22 2008-09-02 Reliant Pharmaceuticals, Inc. System and method for manufacturing oral osmotic drug delivery devices, and methods of administering same
US8956654B2 (en) 2009-06-02 2015-02-17 Dow Global Technologies Llc Sustained release dosage form
WO2015023675A2 (en) 2013-08-12 2015-02-19 Pharmaceutical Manufacturing Research Services, Inc. Extruded immediate release abuse deterrent pill
US9492444B2 (en) 2013-12-17 2016-11-15 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
WO2015095391A1 (en) 2013-12-17 2015-06-25 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
EP3169315B1 (en) 2014-07-17 2020-06-24 Pharmaceutical Manufacturing Research Services, Inc. Immediate release abuse deterrent liquid fill dosage form
EP3209282A4 (en) 2014-10-20 2018-05-23 Pharmaceutical Manufacturing Research Services, Inc. Extended release abuse deterrent liquid fill dosage form
CN106560177A (en) * 2015-09-30 2017-04-12 深圳翰宇药业股份有限公司 Trelagliptin pharmaceutical composition and preparation method thereof
US20180360817A1 (en) * 2015-12-31 2018-12-20 Cadila Healthcare Limited Extended release osmotic dosage form comprising high methylphenidate hydrochloride load

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4765989A (en) * 1983-05-11 1988-08-23 Alza Corporation Osmotic device for administering certain drugs
US5024843A (en) * 1989-09-05 1991-06-18 Alza Corporation Oral hypoglycemic glipizide granulation
US5160744A (en) * 1991-06-27 1992-11-03 Alza Corporation Verapmil therapy
US5713852A (en) * 1995-06-07 1998-02-03 Alza Corporation Oral dosage and method for treating painful conditions of the oral cavity
WO1999062496A1 (en) * 1998-06-03 1999-12-09 Alza Corporation Methods and devices for providing prolonged drug therapy
US20040170680A1 (en) * 2001-05-02 2004-09-02 Benjamin Oshlack Once-a-day oxycodone formulations
WO2006030402A2 (en) * 2004-09-17 2006-03-23 Ranbaxy Laboratories Limited Dual compartment osmotic delivery device

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4765989A (en) * 1983-05-11 1988-08-23 Alza Corporation Osmotic device for administering certain drugs
US5024843A (en) * 1989-09-05 1991-06-18 Alza Corporation Oral hypoglycemic glipizide granulation
US5160744A (en) * 1991-06-27 1992-11-03 Alza Corporation Verapmil therapy
US5713852A (en) * 1995-06-07 1998-02-03 Alza Corporation Oral dosage and method for treating painful conditions of the oral cavity
WO1999062496A1 (en) * 1998-06-03 1999-12-09 Alza Corporation Methods and devices for providing prolonged drug therapy
US20040170680A1 (en) * 2001-05-02 2004-09-02 Benjamin Oshlack Once-a-day oxycodone formulations
WO2006030402A2 (en) * 2004-09-17 2006-03-23 Ranbaxy Laboratories Limited Dual compartment osmotic delivery device

Also Published As

Publication number Publication date
WO2006046114A2 (en) 2006-05-04

Similar Documents

Publication Publication Date Title
WO2006128692A3 (en) 2-oxo-1-pyrrolidine derivatives and their therapeutic use on the central nervous system
AP2405A (en) Cannabinoid active pharmaceutical ingredient for improved dosage forms.
WO2006023627A8 (en) Rapamycin polymorph ii and uses thereof
EP1740156B8 (en) Method for the production of an abuse-proof, solid form of administration
WO2005079756A3 (en) Combination of a nmda receptor antagonist and an anti-depressive drug mao-inhibitor or a gadph-inhibitor for the treatment of psychiatric conditions
WO2007019439A3 (en) Block copolymer compositions and uses thereof
WO2006060547A3 (en) Systems and methods for intra-oral drug delivery
WO2009121039A3 (en) Administration of benzodiazepine compositions
WO2008121767A3 (en) Stitched polypeptides
WO2006007448A3 (en) Pharmaceutical co-crystal compositions and related methods of use
WO2006131591A3 (en) An entacapone-containing oral dosage form
WO2006055603A3 (en) Injectable nanoparticulate olanzapine formulations
WO2007147010A3 (en) Implantable medical devices and methods for making the same
WO2007014930A3 (en) Polyammonium/polysiloxane copolymers
WO2007001888A3 (en) New regimens for controlled drug delivery devices for contraception
WO2007022956A3 (en) Pharmaceutical compositions comprising a ph-dependent drug, a ph modifier and a retarding agent
AP2006003495A0 (en) Agent for inhibiting membrane virus reproduction, method for the production thereof, pharmaceutical composition and method for inhibiting viral infections.
WO2007050793A3 (en) Methods and compositions for the treatment of marfan syndrome and associated disorders
WO2007013666A3 (en) Anti-tumor agents comprising r-spondins
WO2007133944A3 (en) Topical administration of acyclovir
WO2006113568A8 (en) Controlled delivery dosage form of tramadol and gabapentin
WO2006046114A3 (en) Osmotic dosage forms providing ascending drug release, and processes for their preparation
WO2006002077A3 (en) Stable pharmaceutical formulations of benzimidazole compounds
WO2009026257A8 (en) Methods and compositions for controlling the bioavailability of poorly soluble drugs
WO2006118884A3 (en) Drug delivery devices and related components, systems and methods

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BW BY BZ CA CH CN CO CR CU CZ DK DM DZ EC EE EG ES FI GB GD GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV LY MD MG MK MN MW MX MZ NA NG NO NZ OM PG PH PL PT RO RU SC SD SG SK SL SM SY TJ TM TN TR TT TZ UG US UZ VC VN YU ZA ZM

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ NA SD SZ TZ UG ZM ZW AM AZ BY KG MD RU TJ TM AT BE BG CH CY DE DK EE ES FI FR GB GR HU IE IS IT LU LV MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 05809777

Country of ref document: EP

Kind code of ref document: A2